Skip to content

The Effects of Flaxseed Supplement on Weight and Biochemical Factors in Overweight and Obese Subject

The Effects of Flaxseed Supplement on Weight, Lipid Profile and Inflammatory Factors in Overweight and Obese Subjects

Status
Completed
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02410668
Enrollment
50
Registered
2015-04-07
Start date
2014-03-31
Completion date
2015-01-31
Last updated
2015-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overweight and Obesity

Brief summary

To study the effects of Flaxseed supplement on weight, lipid profile and inflammatory factors in subjects with over weight and obesity, 50 patients will be randomly allocated to receive placebo or 30 grams milled Flaxseed for 12 weeks; both groups will be advised to adherence the investigators' diet and exercise program too. At the first and the end of the intervention, weight, waist and hip circumference, lipid profile and some inflammatory markers will be assessed and compared between groups.

Interventions

DIETARY_SUPPLEMENTflaxseed
DIETARY_SUPPLEMENTPlacebo
BEHAVIORALExercise recommendation

Sponsors

National Nutrition and Food Technology Institute
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* Age of 18 to 70 years * Body Mass Index (BMI) between 25-40

Exclusion criteria

* diabetes mellitus * cardiovascular diseases and cancers * major systemic diseases * gastrointestinal problems * liver and renal failure * history of allergy or high consumption of nuts, flaxseed, or sesame seeds * weight loss within the past 6 mo of \>5% of body weight or current adherence to a weight-reduction diet * pregnancy, lactation

Design outcomes

Primary

MeasureTime frame
weight12 weeks
waist and hip circumference12 weeks

Secondary

MeasureTime frame
lipid profile12 weeks

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 21, 2026